Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment. (Q54754869)

3 June 2018

title

Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment. (English)

1 reference

3 June 2018

1 reference

3 June 2018

author name string

Simone Mocellin

1 reference

3 June 2018

Maurizio Provenzano

1 reference

3 June 2018

Pierluigi Pilati

1 reference

3 June 2018

Donato Nitti

1 reference

3 June 2018

Mario Lise

1 reference

3 June 2018

publication date

1 September 2003

1 reference

3 June 2018

Journal of Immunological Methods

published in

1 reference

3 June 2018

volume

280

1 reference

3 June 2018

issue

1-2

1 reference

3 June 2018

page(s)

1-11

1 reference

3 June 2018

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

High levels of IL-4 and IL-10 mRNA and low levels of IL-2, IL-9 and IFN-gamma mRNA in MuLV-induced lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Exploring the new world of the genome with DNA microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

An endotoxin-induced serum factor that causes necrosis of tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Cytokine Dysregulation in Invasive Cervical Carcinoma and Other Human Neoplasias: Time to Consider the TH1/TH2 Paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Analysis of type T1 and T2 cytokines in patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Clinical applications of TNF-alpha in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

T Helper 1 Cytokine mRNA Is Increased in Spontaneously Regressing Primary Melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Cytokines and immune response in the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Short-term kinetics of tumor antigen expression in response to vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

Soft tissue limb sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

A natural history of melanoma: serial gene expression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

High-fidelity mRNA amplification for gene profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900274-6

10.1016/S0022-1759(03)00274-6

7 January 2021

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018